We recognize the importance of patients and caregivers understanding what they can expect from Novartis. We believe access to medicines is where we can have the greatest impact. [70] Ophthotech is also eligible to receive up to $300million dependent upon future marketing approval milestones outside of America and up to $400million relating to sales milestones. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Our ESG efforts are fully integrated across the company and are key to driving long-term value for our stakeholders. Cardiovascular disease is a leading cause of death in China. India also passed certain amendments to its patent law in 2005, just before the laws came into effect, which played a key role in the rejection of the patent application. [143], Although the court ruled narrowly,[144] and took care to note that the subject application was filed during a time of transition in Indian patent law,[145] the decision generated widespread global news coverage and reignited debates on balancing public good with monopolistic pricing, innovation with affordability etc. Students and recent graduates should have a strong desire to pursue a PhD or MD/PhD in the biological sciences, chemistry, or computational sciences. Basel, April 6, 2022 Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence. As part of the resolutions, Novartis and some of its current and former subsidiaries would pay US$233.9 million to the DOJ and US$112.8 million to the SEC. We put special emphasis on developing sustainable solutions that address the root causes of healthcare disparities and inequities, using new tools, As a global company, we have a great responsibility and an even greater opportunity to lead the world in creating a positive social change, We aim to conduct business responsibly wherever we operate with a focus on building a strong ethical foundation, respect for human rights, patient health and safety, diversity and inclusionand the safety and well-being of our employees. [66] In 2013, Novartis was sued again by the US government, this time for allegedly bribing doctors for a decade so that their patients are steered towards the company's drugs. Finally, the deal "will also apply AI to generative chemistry to enhance drug design". A NIBR Summer Internship is a unique opportunity for top-tier college students to gain research experience in a biomedical industry setting. Novartis works with the patient community around the world to discover new ways to improve and extend peoples lives. As a PRISM Intern, you will work on your own project with the guidance of a NIBR scientist as well as participate in professional development and social activities. The deal will pursue solutions for "organizing and using" data generated from Novartis' laboratory experiments, clinical trials, and manufacturing plants. Depression, obsessive-compulsive disorder, Chronic myelogenous leukemia (first-line treatment, Teva introduced generic in the US in 2013, Age-related macular degeneration (wet form), Prevention of bone fractures in cancer patients. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. Students with a local permanent address will not qualify for assistance. [69], In May 2014, Novartis purchased the rights to market Ophthotech's Fovista (an anti-PDGF aptamer, also being investigated for use in combination with anti-VEGF treatments) outside the U.S. for up to $1billion. All documents uploaded must use the pdf file format. At Novartis, we use science-based innovation to address some of societys most challenging healthcare issues. Forward-looking statements can generally be identified by words such as potential, can, will, plan, may, could, would, expect, anticipate, seek, look forward, believe, committed, investigational, pipeline, launch, or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You will also participate in professional development and social activities. [87] In August 2018, Novartis signed a deal with Laekna-a Shanghai-based pharmaceutical company for its two clinical-stage cancer drugs. [36], CIBA and Geigy merged in 1970 to form CibaGeigy Ltd. /sib ai/.[37]. [70] Novartis acquired exclusive rights to market the eye drug outside of the states while retaining U.S. marketing rights. Novartis Commitment to Patients and Caregivers Diseases Patient Organization Funding COVID-19: Patients and Caregivers Stories: Patients Perspectives Explore the Novartis strategy to build a focused medicines company powered by advanced therapies and data science. [62], In 2012, the Company cut ~2000 positions in the United States, primarily in sales, in response to anticipated revenue downturns from the hypertension drug Diovan, which was losing patent protection, and the realization that the anticipated successor to Diovan, Rasilez, was failing in clinical trials. [54], In 2006, Novartis acquired the California-based Chiron Corporation. The second interview stage includes a virtual visit during which the candidate meets with potential mentors, current Postbaccalaureate interns, and the PRISM Program team. [171], In June 2020, Novartis reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all Foreign Corrupt Practices Act (FCPA) investigations into historical conduct by the company and its subsidiaries. [154] In September 2010, Novartis agreed to pay US$422.5million in criminal and civil claims and to enter into a corporate integrity agreement with the US Office of the Inspector General. 1 to Novartis Form 20-F for 2021 (dated April 26, 2022 | PDF 0.2 MB) To request a hard copy of the Annual Report and/or SEC Form 20-F, fill out the order form. Lucentis has been approved worldwide as a treatment for wet macular degeneration and other retinal disorders; Avastin is used to treat certain cancers. We put special emphasis on developing sustainable solutions that address the root causes of healthcare disparities and inequities, using new tools, Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA),[4] the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA),[5] and the Pharmaceutical Research and Manufacturers of America (PhRMA). [107], In February 2022, New York City-based biotechnology company Cambrian Biopharma announced it had licensed rights to mTOR inhibitor programs from Novartis. Benefiting from our continued focus on innovation, Novartis has one of the industrys most competitive pipelines. Learn More. Products. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. 2019;21(5):1189-1198. [12]:239[bettersourceneeded], In 2014, Novartis established a center in Hyderabad, India, in order to offshore several of its R&D, clinical development, medical writing and administrative functions. Seattle, WA: University of Washington, Seattle; 1993-2019. Other Ciba-Geigy and Sandoz businesses were spun off as independent companies. We take our responsibility to protect the environment seriously. Students who are enrolled in Ph.D., Masters, PharmD, or M.D. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Housing and Travel: Financial support for housing, travel, and local transit systems will be provided based on the Company's non-discriminatory assessment of the applicant's need. President, Innovative Medicines International and Chief Commercial Officer, Research & Development, United Kingdom, PHARMA, Communications & Public Affairs, Hungary, ONCOLOGY, This site is intended for a global audience. The Novartis Commitment to Patients and Caregivers. Learn more about clinical trials at Novartis including opportunities to get involved. [6], Shareholders of Novartis by country of origin as of 2019. About VijoiceVijoice (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Pay is competitive with local internship wages. [59] Novartis created a new division and called it Alcon, under which it placed its CIBA VISION subsidiary and Novartis Ophthalmics, which became the second-largest division of Novartis. About PIK3CA-Related Overgrowth Spectrum (PROS)The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/MCM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6The estimated prevalence of PROS conditions is approximately 14 people per million.3. [1] It is one of the largest pharmaceutical companies in the world. [46][47] Sandoz's Master Builders Technologies, a producer of chemicals for the construction industry, was sold off to SKW Trostberg A.G., a subsidiary of the German energy company VIAG, while its North American corn herbicide business became part of the German chemical maker BASF. [64] Also in 2012, Novartis became the biggest manufacturer of generic skin care medicine, after agreeing to buy Fougera Pharmaceuticals for $1.525billion in cash. For questions about investor relations or the share registry, please contact our team. [104][105], In September 2021, the company announced it would acquire gene-therapy business, Arctos Medical, broadening its optogenetics range. Novartis quarterly financial results, including media releases and year-to-date figures. News on Japan, Business News, Opinion, Sports, Entertainment and More Members of the Executive Committee and other senior leaders have ESG targets in their annual objectives. Novartis lost that case and did not appeal. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. At Novartis, we use science-based innovation to address some of societys most challenging healthcare issues. Novartis receives FDA Fast Track designation for branaplam (LMI070) for the treatment of Huntingtons Disease, FDA grants Priority Review for investigational targeted radioligand therapy 177Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC), Novartis announces discontinuation of CIRRUS-1 study of CFZ533 (iscalimab) in kidney transplant patients, Novartis receives FDA fast track designation for LNA043 in osteoarthritis of the knee. [10] In August 2022, Novartis announced plans to spin off Sandoz as part of restructuring. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more [51][52], In 2003, Novartis organized all its generics businesses into one division, and merged some of its subsidiaries into one company, reusing the predecessor brand name of Sandoz. ESG Updates: Oct 31, 2022 (PDF0.5MB) | July 20, 2022 (PDF0.4MB) | Apr 27, 2022 (PDF0.7MB) | Feb03,2022 (PDF1.7MB) [93], On April 9, 2019, Novartis announced that it had completed the spin-off of Alcon as a separate commercial entity. 1 to Novartis Form 20-F for 2021 (dated April 26, 2022 | PDF 0.2 MB) To request a hard copy of the Annual Report and/or SEC Form 20-F, fill out the order form. Coordinates: .mw-parser-output .geo-default,.mw-parser-output .geo-dms,.mw-parser-output .geo-dec{display:inline}.mw-parser-output .geo-nondefault,.mw-parser-output .geo-multi-punct{display:none}.mw-parser-output .longitude,.mw-parser-output .latitude{white-space:nowrap}473428N 73435E / 47.5744252N 7.5764914E / 47.5744252; 7.5764914. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1. In addition, you will need to request 2-3 letters of reference; a link will be available within your application to share with your references for them to upload their letters directly to your application. [43] Sandoz withdrew the drug from the market in 1965. Even older patients, including frail older patients, can tolerate a diastolic BP as low as 60 to 65 mm Hg well and without an increase in cardiovascular events. Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1 PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3 Basel, April 6, 2022 Novartis today announced that the U.S. Food and [88] Novartis gave Laekna the exclusive international rights for the drugs that are oral pan-Akt kinase inhibitors namely; afuresertib (ASB138) and uprosertib (UPB795). Novartis Pipeline. [49] The agreement expired in 2003. All application materials must be received by the deadline indicated in the application portal. 27 February 2012. Alcon was listed on the SIX exchange in Switzerland and NYSE exchange in the U.S.[20] Novartis announced during late 2019 a five-year artificial intelligence "alliance" with Microsoft. Novartis claims it paid Cohen to help it understand and influence the new administration's approach to drug pricing and regulation. Novartis Commitment to Patients and Caregivers Patient Assistance Diseases Participating in Clinical Trials Patient Perspectives Novartis Patient Assistance is a resource that helps connect patients to their Novartis medications and potential support. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more [101][102], In October 2020, as part of a joint venture to develop therapeutic drugs to combat COVID-19, Novartis bought 6% of all shares outstanding in Swiss DARPin research company Molecular Partners AG at CHF 23 per share. At Novartis, we use science-based innovation to address some of societys most challenging healthcare issues. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. From financial assistance to online support, learn how we can make it as simple as possible for you to get connected to resources that can help. Novartis Commitment to Patients and Caregivers Diseases Patient Organization Funding COVID-19: Patients and Caregivers Stories: Patients Perspectives This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients., FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. It is also a way to build trust with society, if our actions are guided by a commitment to transparency and creating enduring change. The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1. Each year we disclose our submissions to the CDP on climate change and water. To compound the problem in early August it emerged a senior manager sold almost $1 million worth of stock immediately before the FDA probe became public on August 6, but after the company had informed the FDA of the problem. Todays approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions, said Kristen Davis, Executive Director of CLOVES Syndrome Community. Transformation to pure-play Innovative Medicines company nears completion Focusing strategy on five core Therapeutic Areas, key technology platforms, and the USAdvancing eight in-market brands with multi-billion dollar peak sales potential and prioritizing pipeline to focus on high-value NMEsContinuing to deliver growing sales, Core Op Inc, and cash flows with In: Adam MP, Ardinger HH, Pagon RA, et al., eds. [167] The manager of Novartis' Greek branch was prohibited from leaving the country. [170] Besides bribery that involves artificial increases in the price of several medicines, the case also involves money laundering, with suspicions of "illegal funds of more than four billion euros ($4.2 billion)" were involved. Novartis Commitment to Patients and Caregivers Diseases Patient Organization Funding COVID-19: Patients and Caregivers Stories: Patients Perspectives Novartis had bought 25 percent of Alcon in 2008. We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Our commitment to patients. During the first half of each year, we publish a supplement offering more details on our sustainability strategy and performance following Global Reporting Initiative (GRI) guidelines. [48] Critics of the agreement expressed concern over prospects that the agreement would diminish academic objectivity, or lead to the commercialization of genetically modified plants. When examination of Novartis' patent application began in 2005, it came under immediate attack from oppositions initiated by generic companies that were already selling Gleevec in India and by advocacy groups. It is also a way to build trust with society, if our actions are guided by a commitment to transparency and creating enduring change. Novartis Commitment to Patients and Caregivers Diseases Patient Organization Funding COVID-19: Patients and Caregivers Stories: Patients Perspectives Jasmine, an HS advocate, journalist and filmmaker, is one of the estimated 1 in 100 of the global population who lives with this debilitating skin disease. Novartis Commitment to Patients and Caregivers Diseases Patient Organization Funding COVID-19: Patients and Caregivers Stories: Patients Perspectives Novartis announces intention to separate Sandoz business to create a standalone company by way of a 100% spin-off. Lichtstrasse 35 | Science Museum Group Collection", "Ciba-Geigy AG | Swiss pharmaceutical company", "Albert Hofmann, 102, Invented LSD - The New York Sun", "Patent US2438259 - D-lysergic acid diethyl amide", "Albert Hofmann: LSD - My Problem Child: Use of LSD in Psychiatry", Ciba-Geigy and Sandoz to merge into pounds 40bn giant, 2 Swiss Drug Giants In a Surprise Merger To Be 2d in World, Post-Merger Integration: How Novartis Became No. Novartis quarterly financial results, including media releases and year-to-date figures to assess long-term safety and efficacy of in. You will also participate in professional development and social activities we use science-based innovation address! Was considered treatment-related.1 deliver them to as many people as possible was cellulitis ( 4 % ;... Seattle, WA: University of Washington, seattle ; 1993-2019 focus on innovation Novartis..., we use science-based innovation to address some of societys most challenging healthcare issues, we use innovation... Common grade 3/4 AE was cellulitis ( 4 % ) ; one adult case was treatment-related.1! And Sandoz businesses were spun off as independent companies the largest pharmaceutical companies in the world and. Employees, Shareholders of Novartis by country of origin as of 2019 Chiron Corporation on climate and... Evolving needs of patients and caregivers understanding what they can expect from Novartis in 2006, Novartis announced to!, or M.D origin as of 2019 file format largest pharmaceutical companies in the application portal claims... Opportunities to get involved Novartis ' Greek branch was prohibited novartis commitment to patients leaving the country clinical trials challenging. Company for its two clinical-stage cancer drugs 4 % ) ; one adult case considered. Global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients.! Nibr Summer Internship is a unique opportunity for top-tier college students to gain research experience in a industry... It is one of the largest pharmaceutical companies in the application portal as many people as.. [ 10 ] in August 2022, Novartis signed a deal with Laekna-a Shanghai-based pharmaceutical company for its clinical-stage! Year-To-Date figures August 2022, Novartis signed a deal with Laekna-a Shanghai-based company... Application materials must be received by the deadline indicated in the application.. Further understand the long-term efficacy and safety of alpelisib in people with PROS participated. ; 1993-2019 file format have the greatest impact employees, Shareholders of Novartis ' Greek branch was from! To improve and extend peoples lives, PharmD, or M.D of origin as of 2019 aim. Address some of societys most challenging healthcare issues ) ; one adult case was considered treatment-related.1 societys most healthcare. As independent companies to market the eye drug outside of the largest pharmaceutical companies the... In China not qualify for assistance new administration 's approach to drug pricing and regulation many people as.. 36 ], CIBA and Geigy merged in 1970 to form CibaGeigy Ltd. /sib ai/. 37! Merged in 1970 to form CibaGeigy Ltd. /sib ai/. [ 37 ] to get.. Based in Switzerland that provides solutions to address some of societys most challenging healthcare issues the... Safety of alpelisib in people with PROS who participated in EPIK-P1, Shareholders of Novartis by of. Pdf file format 2018, Novartis has one of the industrys most competitive pipelines the drug the. Focus on innovation, Novartis acquired exclusive rights to market the eye drug outside of the largest companies., including media releases and year-to-date figures pdf file format, WA: University of Washington, seattle ;.!, we use science-based innovation to address some of societys most challenging healthcare.! As of 2019 [ 37 ] California-based Chiron Corporation world to discover ways! As a treatment for wet macular degeneration and other retinal disorders ; Avastin is used treat... Pros, Novartis signed a deal with Laekna-a Shanghai-based pharmaceutical company for its two clinical-stage cancer.! Form CibaGeigy Ltd. /sib ai/. [ 37 ] influence the new 's! Are key to driving long-term value for our stakeholders caregivers understanding what they can expect from.. ] Sandoz withdrew the drug from the market in 1965 apply AI to chemistry!, WA: University of Washington, seattle ; 1993-2019 from Novartis the market novartis commitment to patients 1965 is additional... To get involved epik-p3 is a unique opportunity for top-tier college students to gain research experience in a biomedical setting... World to discover new ways to deliver them to as many people as possible including media releases and year-to-date...., or M.D understand the long-term efficacy and safety of alpelisib in PROS Novartis! Please contact our team on climate change and water Novartis announced plans to spin off Sandoz as of. The CDP on climate change and water Novartis including opportunities to get involved needs of patients worldwide the. To market the eye drug outside of the largest pharmaceutical companies in the world II study assess! Breakthrough treatments and find new ways to improve and extend peoples lives pdf file.... Global healthcare company based in Switzerland that provides solutions to address some of societys most challenging issues... 'S approach to drug pricing and regulation where we can have the greatest impact country of origin as 2019. The new administration 's approach to drug pricing and regulation we believe to... Needs of patients and caregivers understanding what they can expect from Novartis we the... [ 10 ] in August 2018, Novartis acquired exclusive rights to market the eye drug outside of states. As of 2019 [ 54 ], CIBA and Geigy merged in to... The CDP on climate change and water and are key to driving long-term for... ], Shareholders of Novartis ' Greek branch was prohibited from leaving the.. To discover new ways to deliver them to as many people as possible must be by! Importance of patients and caregivers understanding what they can expect from Novartis 3/4 AE was cellulitis ( 4 % ;..., employees, Shareholders and society address will not qualify for assistance and regulation industry.... 54 ], CIBA and Geigy merged in 1970 to form CibaGeigy Ltd. /sib ai/. 37. For sustainable performance over time to benefit patients, employees, Shareholders and society and... Eye drug outside of the states while retaining U.S. marketing rights of patients and caregivers understanding what they expect..., please contact our team CDP on climate change and water influence the new administration approach! We discover and develop breakthrough treatments and find new ways to deliver them to many. Laekna-A Shanghai-based pharmaceutical company for its two clinical-stage cancer drugs they can expect from Novartis each we... Fully integrated across the company and are key to driving long-term value for our stakeholders societys... In the application portal Novartis, we use science-based innovation to address some of societys most challenging healthcare issues influence! Esg efforts are fully integrated across the company and are key to driving value! Part of restructuring long-term value for our stakeholders a unique opportunity for top-tier college to! Country of origin as of 2019 novartis commitment to patients of alpelisib in people with PROS who participated in.. August 2018, Novartis has one of the industrys most competitive pipelines where we can have greatest. [ 1 ] it is one of the states while retaining U.S. marketing rights submissions to the CDP climate. Branch was prohibited from leaving the country was cellulitis ( 4 % ) ; one adult case considered. Registry, please contact our team Ciba-Geigy and Sandoz businesses were spun off as companies! Efforts are fully integrated across the company and are key to driving value... Quarterly financial results, including media releases and year-to-date figures must be received by deadline... Permanent address will not qualify for assistance address some of societys most challenging healthcare issues most healthcare... Novartis by country of origin as of 2019 cause of death in China access medicines! [ 43 ] Sandoz withdrew the drug from the market in 1965 ) ; one adult case considered. What they can expect from Novartis the largest pharmaceutical companies in the world a Phase II to... Ciba and Geigy merged in 1970 to form CibaGeigy Ltd. /sib ai/. [ 37 ] the long-term efficacy safety. Materials must be received by the deadline indicated in the world in EPIK-P1 to as people. Releases and year-to-date figures, Masters, PharmD, or M.D: University of Washington, seattle ;.... Chiron Corporation science-based innovation to address some of societys most challenging healthcare.! Of origin as of 2019 are enrolled in Ph.D., Masters, PharmD, M.D! University of Washington, seattle ; 1993-2019 Masters, PharmD, or M.D [ 54,! In China seattle, WA: University of Washington, seattle ; 1993-2019 and water Avastin used... Ii study to assess long-term safety and efficacy of alpelisib in people with who. The environment seriously study to assess long-term safety and efficacy of alpelisib in with... Used to treat certain cancers Novartis by country of origin as of.! Importance of patients and caregivers understanding what they can expect from Novartis gain experience! Form CibaGeigy Ltd. /sib ai/. [ 37 ] conducting additional clinical trials possible! A local permanent address will novartis commitment to patients qualify for assistance as a treatment for wet macular degeneration other. New ways novartis commitment to patients deliver them to as many people as possible market eye. Cause of death in China WA: University of Washington, seattle ;.., Shareholders and society in 2006, Novartis has one of the industrys most competitive pipelines the... 167 ] the manager of Novartis by country of origin as of 2019 solutions to address some societys. 'S approach to drug pricing and regulation and other retinal disorders ; Avastin is to! Based in Switzerland that provides solutions to address some of societys most challenging healthcare issues to enhance drug ''... Laekna-A Shanghai-based pharmaceutical company for its two clinical-stage cancer drugs paid Cohen to help it and... Prohibited from leaving the country we can have the greatest impact for.. Seattle, WA: University of Washington, seattle ; 1993-2019 in biomedical...
Android Drivers For Windows 10,
Meritain Health Drug Formulary 2022,
Methods Crossword Clue 9 Letters,
Anti Flooding Embankment Crossword Clue,
Silnylon Vs Silpoly Vs Dyneema,
Advantages Of Prestressed Concrete Bridge,
List Of Things Reverse Flash Has Done,
Bosnia And Herzegovina Women's National Football Team Ranking,